Merck launches Phase 3 trial of Ohtuvayre for COPD exacerbation prevention

Vivesto secures US orphan drug designation for Cantrixil in acute myeloid leukemia

Lytix Biopharma's ruxotemitide combination meets primary endpoint in Phase II melanoma trial

Ultima Genomics UG200 Sequencing Platform selected for SG-INSIGHT study

Fresenius and WuXi Biologics agree biosimilars development partnership

POLYTECH Health & Aesthetics partners with London Regenerative Institute on adipose tissue processing in aesthetic and reconstructive surgery

Acumen Pharmaceuticals phase 2 Alzheimer's trial misses primary endpoint

Immunome secures EMA validation of varegacestat application for desmoid tumors

FDA approves Sun Pharma's ILUMYA for psoriatic arthritis

Alkermes initiates phase 2 study of ALKS 7290 for major depressive disorder

Phrontline Biopharma reports preliminary safety and antitumour activity for TJ101

HR HealthCare establishes charitable arm

Sobi presents phase 3 gout study results for pozdeutinurad

TME Pharma signs exclusive negotiation agreement with Japan's TMS for NOX-A12 rights

Formation Bio establishes USD600m debut fund for drug development